К содержанию
MMadical AI Use

Source record

REACH VET outreach for veterans at highest statistical risk

ОпубликованоСтатья

Текст показан по-английски, пока нет перевода.

The source is McCarthy and colleagues, Psychiatric Services, February 2023, a program evaluation of REACH VET in the Veterans Health Administration. The model runs monthly on patients seen in the prior two years, and policy expects outreach to the top 0.1% at each facility. By late 2020 nearly all identified veterans had been contacted and had care reviewed. After age and sex adjustment, the paper associated the program with a 5% lower probability of a documented suicide attempt, plus more outpatient contact and safety planning. That is a program association, not a prediction of an individual death.

Source date
1 февр. 2023 г. · Год 2023
Evidence label
Опубликовано
Source type
Статья

Citation

McCarthy et al., Psychiatric Services

McCarthy et al. Program evaluation of REACH VET suicide-risk modeling and outreach in the Veterans Health Administration. Psychiatric Services, February 2023. https://psychiatryonline.org/doi/10.1176/appi.ps.202100629

Key public facts

  • REACH VET is a Veterans Health Administration program. A statistical model flags a very small top tier of risk each month.
  • The model runs on patients seen in the prior two years. Policy expects outreach to the top 0.1% tier at each facility.
  • A clinician who knows the patient reviews the chart and makes contact. Identification is not a diagnosis of suicidal intent.
  • A program evaluation reported that by late 2020 nearly all identified veterans had been contacted and had care reviewed.
  • After age and sex adjustment, the paper associated the program with a 5% lower probability of a documented suicide attempt, plus more outpatient contact and safety planning. It does not say the score predicts an individual death.
Original link

Opens the publisher page in a new tab.

Back to the case

Запись для обучения и обзора рынка. Не совет и не поддержка.

Спонсор

Доберитесь до клинических читателей этого указателя.

О спонсорстве